Evidence map›Paper›PMID 36676074›Full record

ReviewLife (Basel, Switzerland)2023

Berberine-A Promising Therapeutic Approach to Polycystic Ovary Syndrome in Infertile/Pregnant Women.

Oana-Maria Ionescu, Francesca Frincu, Andra Mehedintu, Mihaela Plotogea, Monica Cirstoiu, Aida Petca, Valentin Varlas, Claudia Mehedintu

Open access · goldAbstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Screening of Optimal Phytoconstituents throughCurrent pharmaceutical design · 2025
    Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Oana-Maria IonescuFaculty of Medicine "Carol Davila", University of Medicine and Pharmacy Bucharest, 050474 Bucharest, Romania.
Francesca FrincuFaculty of Medicine "Carol Davila", University of Medicine and Pharmacy Bucharest, 050474 Bucharest, Romania.ORCID 0000-0003-2746-6153
Andra MehedintuFaculty of Medicine "Carol Davila", University of Medicine and Pharmacy Bucharest, 050474 Bucharest, Romania.
Mihaela PlotogeaDepartment of Obstetrics and Gynecology, "Nicolae Malaxa" Clinical Hospital, 022441 Bucharest, Romania.ORCID 0000-0002-0931-0596
Monica CirstoiuFaculty of Medicine "Carol Davila", University of Medicine and Pharmacy Bucharest, 050474 Bucharest, Romania.
Aida PetcaFaculty of Medicine "Carol Davila", University of Medicine and Pharmacy Bucharest, 050474 Bucharest, Romania.ORCID 0000-0002-4890-0978
Valentin VarlasFaculty of Medicine "Carol Davila", University of Medicine and Pharmacy Bucharest, 050474 Bucharest, Romania.ORCID 0000-0002-8342-9819
Claudia MehedintuFaculty of Medicine "Carol Davila", University of Medicine and Pharmacy Bucharest, 050474 Bucharest, Romania.
Carol Davila University of Medicine and Pharmacy · ROClinical Emergency Hospital Bucharest · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polycystic ovary syndrome (PCOS) is a disorder with an unknown etiology that features a wide range of endocrine and metabolic abnormalities that hamper fertility. PCOS women experience difficulties getting pregnant, and if pregnant, they are prone to miscarriage, gestational diabetes, pregnancy-induced hypertension and preeclampsia, high fetal morbidity, and perinatal mortality. Insulin, the pancreatic hormone best known for its important role in glucose metabolism, has an underrated position in reproduction. PCOS women who have associated insulin resistance (with consequent hyperinsulinemia) have fertility issues and adverse pregnancy outcomes. Lowering the endogen insulin levels and insulin resistance appears to be a target to improve fertility and pregnancy outcomes in those women. Berberine is an alkaloid with a high concentration in various medicinal herbs that exhibits a hypoglycaemic effect alongside a broad range of other therapeutic activities. Its medical benefits may stand up for treating different conditions, including diabetes mellitus. So far, a small number of pharmacological/clinical trials available in the English language draw attention towards the good results of berberine's use in PCOS women with insulin resistance for improving fertility and pregnancy outcomes. Our study aims to uncover how berberine can counteract the negative effect of insulin resistance in PCOS women and improve fertility and pregnancy outcomes.

Indexed as

berberineinfertilityinsulin resistancepolycystic ovary syndromepregnancy

Identifiers

PMID36676074
PMCPMC9864590
OpenAlexW4313471813

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.